Meanwhile, one of its paralogs LRRC4 has been shown to have a putative tumor suppressor role in glioma by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-κB pathway (67). This evidence concerns the gene AKT1 and central nervous system cancer.